LumaCyte Invited for Keynote Presentation at NIWeek 2016

CHARLOTTESVILLE, Va., Aug. 2, 2016 /PRNewswire/ —  LumaCyte is likely to be highlighted at NIWeek 2016 in Austin, Tx, US from July 1st to 4th. Your Vicepresident of Application and Technology, Dr. Christopher R. Area, is likely to be showing the Perspective Summit keynote speech on Tuesday, August 2nd. National Instruments (NI) is worldwide organization that retains its annual meeting at the start of July to emphasize modern systems that use their goods. NI requested LumaCyte to provide a keynote centered on our sophisticated single-cell evaluation device, RadianceTM. Dr. Area is likely to be showing about the transformational Laser Pressure Cytology (LFC) technology produced by LumaCyte using NI resources. Their demonstration may function the tale of LumaCyteis effective move from the model device in to the cutting edge item, RadianceTM, that it’s nowadays.

About LumaCyte:

LumaCyte can be an advanced study and device development organization headquartered in Charlottesville, VA. LumaCyte creates generation cell evaluation and working instrumentation that doesn’t need innate labelling for evaluation of mammalian tissues or the usage of antibody. This innovative technology employs fluidic and visual forces inside a microfluidic system to recognize and calculate innate qualities of solitary cells. Programs of LumaCyteis tag- system engineering that is free contain contagious illness, cancer biology, viral contamination, and pre clinical drug development.

Since starting its flagship tag-free single-cell evaluation device, Radiance, in May 2016, LumaCyte hasbeen dealing with clients within the vaccine production room for quick automatic viral contamination measurements. “The need and curiosity from our clients hasbeen large and we’re excited to become dealing with them to improve manufacturing effectiveness and enhance their production procedures”, suggests boss Sean T. Hart  

Picture – http://photos.prnewswire.com/prnh/20160802/395010

SUPPLY LumaCyte

Leave a Reply

Your email address will not be published. Required fields are marked *